Collard Craig A bought HRTX
April 3, 2026 · Form 4 insider transaction
Collard Craig A bought 62,500 shares of Heron Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
62,500
Price
N/A
Total value
N/A
InsiderCollard Craig A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 3, 2026
Filing dateApril 6, 2026
Shares owned after648,255
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock.; Includes 14,045 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2025.